Massey biostatistician develops state-of-the-art statistical models to predict oral cancers and periodontal diseases
VCU Massey Cancer Center researcher Dipankar Bandyopadhyay, Ph.D., constructs statistical models to better understand the causes and patterns of oral cancers and periodontal diseases that may potentially lead to the development of novel therapies to more effectively treat these diseases. He joined Massey as a member of the Cancer Prevention and Control (CPC) research program in 2016 and is also the director of Massey’s Biostatistics Shared Resource Core and a professor in biostatistics at the VCU School of Medicine.
Massey showcases world-class research at its annual Cancer Research Retreat
On Friday, June 16, researchers from across Virginia Commonwealth University took part in Massey Cancer Center’s annual Cancer Research Retreat. While there was no formal theme, many of the morning’s presentations detailed research relating to smoking cessation and the development of new therapies to treat lung cancer.
Massey scientists may have found a new way to halt lung cancer growth
The gene p53 functions normally as a cancer suppressor, but mutated versions of the gene have been implicated in the development and growth of nearly half of all human cancers. Now, for the first time, scientists at VCU Massey Cancer Center have uncovered a mechanism that makes lung cancer cells dependent on mutated versions of the gene, opening the potential for new, more effective treatments.
Massey now offering HIPEC for advanced abdominal cancers
VCU Massey Cancer Center recently became the only cancer care provider in Richmond and one of only a handful in the state to offer heated intraperitoneal chemotherapy (HIPEC), a complex procedure used to treat advanced abdominal cancers.
Second opinions led to improved care and a clinical trial
Richmonder Bindu Panapalli’s experience with ovarian cancer has been difficult, but it’s hard to tell due to her cheerful disposition and contagious laugh. She recently finished treatments for ovarian cancer, and is now participating in a clinical trial studying the effects of diet and exercise on ovarian cancer recurrence.